<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="Figure" xml:lang="en" id="pbi13194-fig-0005" orientation="portrait" position="float">
 <label>Figure 5</label>
 <caption>
  <p>Antibody‐dependent enhancement of 
   <styled-content style="fixed-case" toggle="no">CHKV</styled-content>mabs for 
   <styled-content style="fixed-case" toggle="no">DENV</styled-content> infection. Serial dilutions of 
   <styled-content style="fixed-case" toggle="no">CHKV</styled-content>mabs or 4G2 (positive control 
   <styled-content style="fixed-case" toggle="no">mA</styled-content>b) were mixed with 
   <styled-content style="fixed-case" toggle="no">DENV</styled-content>‐2 and then incubated with Fcγ
   <styled-content style="fixed-case" toggle="no">RII</styled-content>a
   <sup>+</sup> K562 cells. Cells were fixed, permeabilized and stained with an anti‐
   <styled-content style="fixed-case" toggle="no">DENV</styled-content> E antibody and analysed by flow cytometry.
  </p>
 </caption>
 <graphic id="nlm-graphic-9" xlink:href="PBI-18-266-g005" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
